BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John Kim has downgraded Sabra Health Care REIT (NASDAQ:SBRA) from Outperform to Market Perform and set a price target of $16.
October 17, 2023 | 11:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sabra Health Care REIT has been downgraded by BMO Capital, which could potentially impact its stock price negatively in the short term.
Analyst ratings often influence investor sentiment and can impact stock prices. The downgrade from Outperform to Market Perform suggests that BMO Capital believes SBRA's stock will perform similarly to the overall market, rather than outperforming it. This, combined with the set price target, could potentially lead to a decrease in SBRA's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100